Recombinant Human DC-UbP Protein，GST

DC-UbP, or Deubiquitinating Enzyme C-terminal ubiquitin-like protein, has garnered significant attention in recent years due to its crucial role in regulating protein homeostasis and cellular signaling pathways. Ubiquitination, a post-translational modification involving the addition of ubiquitin to proteins, is essential for various cellular processes, including protein degradation, cell cycle regulation, and stress responses. Dysregulation of ubiquitination has been implicated in numerous diseases, including cancer, neurodegeneration, and inflammatory disorders. DC-UbP appears to play a vital role in counteracting ubiquitination by removing ubiquitin moieties from target proteins, thus modulating their stability and function. Research into DC-UbP has revealed its potential as a therapeutic target, as enhancing its activity could restore normal cellular functions disrupted by aberrant ubiquitination. Current studies focus on elucidating the structural and functional characteristics of DC-UbP, exploring its interaction with various substrates, and examining its regulatory mechanisms within the ubiquitin-proteasome system. Understanding the detailed biochemistry of DC-UbP will not only enhance our knowledge of ubiquitin-mediated processes but also open new avenues for the development of targeted therapies in diseases related to ubiquitin dysregulation. This is critical as the demand for novel therapeutic strategies is urgent in light of the rising prevalence of conditions linked to ubiquitin system malfunction.